Safety, Tolerability and Efficacy of Intravitreal KIO-104 in Patients With Macular Edema
Clinical trial NCT06825702 · RECRUITING
Trial details
- NCT number
- NCT06825702
- Sponsor
- Kiora Pharmaceuticals, Inc.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-01
- Primary completion
- 2026-11-01
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.